Login / Signup
Senyao Shao
ORCID
Publication Activity (10 Years)
Years Active: 2022-2022
Publications (10 Years): 1
Top Topics
Dna Damage
Endoplasmic Reticulum Stress
Cancer Therapy
Crispr Cas
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Felix Oppel
,
Senyao Shao
,
Sarah Gendreizig
,
Mark W Zimmerman
,
Matthias Schürmann
,
Viyof Ful Flavian
,
Peter Kin Cho Goon
,
Susan N Chi
,
Jon C Aster
,
Holger Sudhoff
,
A Thomas Look
p53 Pathway Inactivation Drives SMARCB1-deficient p53-wildtype Epithelioid Sarcoma Onset Indicating Therapeutic Vulnerability Through MDM2 Inhibition.
Molecular cancer therapeutics
21 (11) (2022)